Related references
Note: Only part of the references are listed.Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis
Hisham Mehanna et al.
LANCET ONCOLOGY (2023)
OC-0105 Incidence and survival after HPV+ and HPV- oropharynx cancer in Denmark 1986-2020 - A DAHANCA study
P. Lassen et al.
RADIOTHERAPY AND ONCOLOGY (2023)
Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts
Pernille Lassen et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Targeted Next Generation Sequencing for Human Papillomavirus Genotyping in Cervical Liquid-Based Cytology Samples
Karoline Andersen et al.
CANCERS (2022)
The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines
Kenneth Jensen et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts
Jacob Kinggaard Lilja-Fischer et al.
ACTA ONCOLOGICA (2019)
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Hisham Mehanna et al.
LANCET (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
5-Y update of the randomized phase III trial DAHANCA19: Primary (Chemo) RT ± zalutumumab in HNSCC
J. G. Eriksen et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Novel nomograms for survival and progression in HPV plus and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients
Christian Gronhoj Larsen et al.
ONCOTARGET (2016)
Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study
Jens Bentzen et al.
ACTA ONCOLOGICA (2015)
p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: A guide for interpretative relevance and consistency
Adel K. El-Naggar et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Scoring and classification of oropharyngeal carcinoma based on HPV-related p16-expression
Pernille Lassen et al.
RADIOTHERAPY AND ONCOLOGY (2012)
The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome
Pernille Lassen
RADIOTHERAPY AND ONCOLOGY (2010)
Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck
Pernille Lassen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Share Paper
